 Home > Medical News > Latest Medical News > Genting Xinyao Announces SPR206 Clinical Trial Application Approved by the National Medical Products Administration

Genting Xinyao Announces SPR206 Clinical Trial Application Approved by the National Medical Products Administration

 Last Update: 2021-10-23
 Source: Internet
 Author: User

Tags

biggest manufacturing companies

loctite application guide

Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com

Shanghai, September 24, 2021/PRNewswire/ - Everest Medicines (HKEX 1952.

Zhu Xu, Chief Medical Officer of Genting Shinya's Infection Field, said: "In recent decades, the emergence of multidrug-resistant (MDR) gram-negative bacteria and the nosocomial infections caused by them are increasingly becoming a thorny global challenge

Dr.

Genting Shining’s partner Spero Therapeutics previously published the first phase 1 double-blind, placebo-controlled single-dose escalation (SAD) and multiple-dose escalation (MAD) clinical trial data of SPR206.

About SPR206

SPR206 is a potential class-leading new polymyxin antibiotic, designed to reduce the current clinical toxicity of polymyxin B and colistin treatment, especially renal toxicity

According to the license agreement between Genting Shinyao and Spero earlier, Genting Shinyao has the development, manufacturing and commercialization of SPR206 for the treatment of multidrug-resistant (MDR) Gram-negative bacterial infections in Greater China, South Korea and some Southeast Asian countries.

About Genting Shinyao

Genting Xinyao is a biopharmaceutical company focusing on the development and commercialization of innovative drugs, dedicated to meeting the unmet medical needs of the Asian market

Source: Genting Shinyao

This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

Related Products

L-Ascorbate-2-Monophosphate Feed Grade

CAS No.: 109620-90-8

Feed Grade

Potassium Sorbate from reliable manufacturer

CAS No.: 590-00-1

Food Grade

Doxycycline Hydrochloride

CAS No.: 10592-13-9

Pharmaceutical Grade

Hot Tags

united states jobs(223)

jobs united states(236)

1 year treasury(277)

1 year subscription(296)

single use technology(195)

announcements today(81)

ups united states(221)

united states logo(227)

80 20 company(94)

healthy food name(42)

Hot Articles

The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.